Generalized anxiety disorder (GAD) is a neuropsychological disorder, under the class of anxiety disorders characterized by excessive and uncontrollable worrying for six or more months. GAD is a major hurdle for personal and social productivity and a financial burden on governmental health sectors; moreover, it is one of the common mental health problems in Saudi Arabia and globally with physical and psychological manifestations (e.g., muscle tension, sleeplessness, disoriented thoughts, etc.). Although, there is not a mono-factor’s direct causality of pathogenesis, there are multiple risk factors such as genetics, socioeconomic status, and life experiences that may contribute to the development of GAD. Nonetheless, the diagnosis is made using the criteria set by the diagnostic and statistical manual of mental disorders, 5th edition (DSM-5) or the international classification of diseases 11th revision (ICD-11), which covers the patient’s past medical history and present social and environmental setting. The management of GAD includes a combination of psychiatric interventions (e.g., cognitive behavioral therapy) and different medications (e.g., selective-serotonin reuptake inhibitors) requiring thorough investigations and deep discussions with the patient to rule out other psychiatric conditions and to reach an optimal level of healthcare, preventing further deterioration. This article addresses the etiology, epidemiology, pathophysiology, diagnosis, and management of GAD in Saudi Arabia to present an integrated and updated review.
Alahmadi, A. M. (2019). Prevalence of Anxiety among College and School Students in Saudi Arabia: A Systematic Review. Journal of Health Informatics in Developing Countries, 13, 1-15. https://www.jhidc.org/index.php/jhidc/article/view/237
Alamri, H. S., Algarni, A., Shehata, S. F. et al. (2021). Prevalence of Depression, Anxiety, and Stress among the General Population in Saudi Arabia during Covid-19 Pandemic. International Journal of Environmental Research and Public Health, 17, 9183. https://doi.org/10.3390/ijerph17249183
Alegría, A., Hasin, D., Nunes, E. et al. (2019). Comorbidity of Generalized Anxiety Disorder and Substance Use Disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Clinical Psychiatry, 71, 1187-1195. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951633
Aljurbua, F. I., Selaihem, A., Alomari, N. A., & Alrashoud, A. M. (2021). A Cross-Sectional Study on Generalized Anxiety Disorder and Its Socio-Demographic Correlates among the General Population in Saudi Arabia. Journal of Family Medicine and Primary Care, 10, 3644. https://doi.org/10.4103/jfmpc.jfmpc_847_21
Alyami, H. S., Naser, A. Y., Dahmash, E. Z. et al. (2019). Depression and Anxiety during 2019 Coronavirus Disease Pandemic in Saudi Arabia: A Cross-Sectional Study. International Journal of Clinical Practice. https://doi.org/10.1101/2020.05.09.20096677
Arul, A. S. (2016). Study of Life Events and Personality Dimensions in Generalized Anxiety Disorder. Journal of Clinical and Diagnostic Research: JCDR, 10, VC05-VC09. https://doi.org/10.7860/JCDR/2016/18123.7652
Baldwin, D. (2019). Generalized Anxiety Disorder in Adults: Epidemiology, Pathogenesis, Clinical Manifestations, Course, Assessment, and Diagnosis. UpToDate. https://www.uptodate.com/contents/generalized-anxiety-disorder-in-adults-epidemiology-pathogenesis-clinical-manifestations-course-assessment-and-diagnosis#H448541483
Bandelow, B., Michaelis, S., & Wedekind, D. (2017). Treatment of Anxiety Disorders. Dialogues in Clinical Neuroscience, 19, 93-107. https://doi.org/10.31887/DCNS.2017.19.2/bbandelow
Berryhill, M. B. (2019). Video Conferencing Psychological Therapy and Anxiety: A Systematic Review. Family Practice, 36, 53-63.
Bystritsky, A. (2019). Uptodate. https://www.uptodate.com/contents/pharmacotherapy-for-generalized-anxiety-disorder-in-adults
Chand, S. P., Kuckel, D. P., & Huecker, M. R. (2022) Cognitive Behavior Therapy. StatPearls Publishing, Treasure Island. https://www.ncbi.nlm.nih.gov/books/NBK470241/
Craske, M. (2020). Approach to Treating Generalized Anxiety Disorder in Adults. UPTODATE.
Diekhof, E. K., Geier, K., Falkai, P., & Gruber, O. (2011). Fear Is Only as Deep as the Mind Allows: A Coordinate-Based Meta-Analysis of Neuroimaging Studies on the Regulation of Negative Affect. Neuroimage, 58, 275-285. https://doi.org/10.1016/j.neuroimage.2011.05.073
DSM-5 (2013). Generalized Anxiety Disorder. Diagnostic and Statistical Manual of Mental Disorders (5th ed., pp. 222-226). American Psychiatric Publishing.
Fioranelli, M., Bottaccioli, A. G., et al. (2018) Stress and Inflammation in Coronary Artery Disease: A Review Psycho-Neuro-Endocrine-Immunology-Based. Frontiers in Immunology, 9, 2031. https://doi.org/10.3389/fimmu.2018.02031
Firth, J. (2017). Can Smartphone Mental Health Interventions Reduce Symptoms of Anxiety? A Meta-Analysis of Randomized Controlled Trials. Journal of Affective Disorders, 218, 15-22. https://doi.org/10.1016/j.jad.2017.04.046
Francis, J. L. (2012). Life Stress and GAD. Depression and Anxiety, 29, 5. https://doi.org/10.1002/da.20919
Gale, C. (2020). Generalised Anxiety Disorder. https://bestpractice-bmj-com.sdl.idm.oclc.org/topics/en-gb/120
Gosschalk, M. G. (2017). Genetics of Generalized Anxiety Disorder and Related Traits. Dialogues in Clinical Neuroscience, 19, 159-168. https://doi.org/10.31887/DCNS.2017.19.2/kdomschke
Griebel, G., & Holsboer, F. (2012). Neuropeptide Receptor Ligands as Drugs for Psychiatric Diseases: The End of the Beginning? Nature Reviews Drug Discovery, 11, 462-478. https://doi.org/10.1038/nrd3702
Grillon, C., O’Connell, K., Lieberman, L. et al. (2017). Distinct Responses to Predictable and Unpredictable Threat in Anxiety Pathologies: Effect of Panic Attack. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2, 575-581. https://doi.org/10.1016/j.bpsc.2016.08.005
Hariri, A., Drabant, E., Munoz, K. et al. (2005). A Susceptibility Gene for Affective Disorders and the Response of the Human Amygdala. Archives of General Psychiatry, 62, 146. https://doi.org/10.1001/archpsyc.62.2.146
Hilbert, K., Lueken, U., & Beesdo-Baum, K. (2014). Neural Structures, Functioning and Connectivity in Generalized Anxiety Disorder and Interaction with Neuroendocrine Systems: A Systematic Review. Journal of Affective Disorders, 158, 114-126. https://doi.org/10.1016/j.jad.2014.01.022
Hoge, E. A., Ivkovic, A., & Fricchione, G. L. (2012). Generalized Anxiety Disorder: Diagnosis and Treatment. BMJ: British Medical Journal, 345, e7500. https://doi.org/10.1136/bmj.e7500
Hompes, T., Izzi, B., Gellens, E. et al. (2013). Investigating the Influence of Maternal Cortisol and Emotional State during Pregnancy on the DNA Methylation Status of the Glucocorticoid Receptor Gene (NR3C1) Promoter Region in Cord Blood. Journal of Psychiatric Research, 47, 880-891. https://doi.org/10.1016/j.jpsychires.2013.03.009
Ibrahim, N., Dania, A. K., Lamis, E. K. et al. (2013). Prevalence and Predictors of Anxiety and Depression among Female Medical Students in King Abdulaziz University, Jeddah, Saudi Arabia. Iranian Journal of Public Health, 42, 726.
Locke, A., Kirst, N., & Shultz, C. (2015). Diagnosis and Management of Generalized Anxiety Disorder and Panic Disorder in Adults. American Family Physician, 91, 617-624. https://www.aafp.org/afp/2015/0501/p617.html
Makovac, E., Meeten, F., Watson, D. R., et al. (2016) Alterations in Amygdala-Prefrontal Functional Connectivity Account for Excessive Worry and Autonomic Dysregulation in Generalized Anxiety Disorder. Biological Psychiatry, 80, 786-795. https://doi.org/10.1016/j.biopsych.2015.10.013
Mantella, R. C., Butters, M. A., Amico, J. A. et al. (2008). Salivary Cortisol Is Associated with Diagnosis and Severity of Late-Life Generalized Anxiety Disorder. Psychoneuroendocrinology, 33, 773-781. https://doi.org/10.1016/j.psyneuen.2008.03.002
Mathew, S. J., Amiel, J. M., Coplan, J. D. et al. (2005). Open-Label Trial of Riluzole in Generalized Anxiety Disorder. American Journal of Psychiatry, 162, 2379-2381. https://doi.org/10.1176/appi.ajp.162.12.2379
Mennin, D., Heimberg, R., & Jack, M. (2000). Comorbid Generalized Anxiety Disorder in Primary Social Phobia. Journal of Anxiety Disorders, 14, 325-343. https://doi.org/10.1016/S0887-6185(00)00026-8
Moller, E. L. (2016). Parenting Behaviors and Anxiety Meta-Analysis. Clinical Psychology Review.
Murphy, T. M., O’Donovan, A., et al. (2015) Anxiety is Associated with Higher Levels of Global DNA Methylation and Altered Expression of Epigenetic and Interleukin-6 Genes. Psychiatric Genetics, 25, 71-78. https://doi.org/10.1097/YPG.0000000000000055
Nemeroff, C. B. (2003). The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders. Psychopharmacology Bulletin, 37, 133-146.
Non, A. L., Binder, A. M., Kubzansky, L. D., & Michels, K. B. (2014) Genome-Wide DNA Methylation in Neonates Exposed to Maternal Depression, Anxiety, or SSRI Medication during Pregnancy. Epigenetics, 9, 964-972. https://doi.org/10.4161/epi.28853
Nutt, D. J. (2001). Neurobiological Mechanisms in Generalized Anxiety Disorder. Journal of Clinical Psychiatry, 62, 22-28.
O’Donohue, W., & Fisher, J. (2012). Cognitive Behavior Therapy (pp. 86-88). Wiley.
Patriquin, M., & Mathew, S. (2017). The Neurobiological Mechanisms of Generalized Anxiety Disorder and Chronic Stress. Chronic Stress (Thousand Oaks), 1. https://doi.org/10.1177/2470547017703993
Pittenger, C., Coric, V., Banasr, M. et al. (2008). Riluzole in the Treatment of Mood and Anxiety Disorders. CNS Drugs, 22, 761-786. https://doi.org/10.2165/00023210-200822090-00004
Rakel, R., Rakel, D., & Ahmed, S. (2016). Textbook of Family Medicine (9th ed.). Elsevier/Saunders.
Ray, S., & Stowe, Z. N. (2014). The Use of Antidepressant Medication in Pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology, 28, 71-83. https://doi.org/10.1016/j.bpobgyn.2013.09.005
Ritchie, H., & Roser, M. (2022). Mental Health. Our World in Data. https://ourworldindata.org/mental-health#anxiety-disorders
Roy, A. K., Fudge, J. L., Kelly, C. et al. (2013). Intrinsic Functional Connectivity of Amygdala-Based Networks in Adolescent Generalized Anxiety Disorder. The Journal of the American Academy of Child & Adolescent Psychiatry, 52, 290-299.e2. https://doi.org/10.1016/j.jaac.2012.12.010
Sajdyk, T. J., Shekhar, A., & Gehlert, D. R. (2004). Interactions between NPY and CRF in the Amygdala to Regulate Emotionality. Neuropeptides, 38, 225-234. https://doi.org/10.1016/j.npep.2004.05.006
Samreen, S., Siddiqui, N. A., & Mothana, R. A. (2020). Prevalence of Anxiety and Associated Factors among Pharmacy Students in Saudi Arabia: A Cross-Sectional Study? BioMed Research International, 2020, Article ID: 2436538. https://doi.org/10.1155/2020/2436538
Strawn, J., Geracioti, L., Rajdev, N. et al. (2018). Pharmacotherapy for Generalized Anxiety Disorder in Adult and Pediatric Patients: An Evidence-Based Treatment Review. Expert Opinion on Pharmacotherapy, 19, 1057-1070. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340395
Turkistani, I., Nuqali, A., Badawi, M. et al. (2014). The Prevalence of Anxiety and Depression among End-Stage Renal Disease Patients on Hemodialysis in Saudi Arabia. Renal Failure, 36, 1510-1515. https://doi.org/10.3109/0886022X.2014.949761
Wang, H., Wong, P. T., Spiess, J., & Zhu, Y. Z. (2005). Cholecystokinin-2 (CCK2) Receptor-Mediated Anxiety-Like Behaviors in Rats. Neuroscience & Biobehavioral Reviews, 29, 1361-1373. https://doi.org/10.1016/j.neubiorev.2005.05.008
Wilkinson, A., Meares, K., & Freeston, M. (2011). CBT for Worry and Generalised Anxiety Disorder. Sage. https://doi.org/10.4135/9781446289105
Zbozinek, T., Rose, R., Wolitzky-Taylor, K. et al. (2012). Diagnostic Overlap of Generalized Anxiety Disorder and Major Depressive Disorder in a Primary Care Sample. Depress Anxiety, 29, 1065-1071. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629816
Zhu, Z., Zhang, L., Jiang, J. et al. (2014). Comparison of Psychological Placebo and Waiting List Control Conditions in the Assessment of Cognitive Behavioral Therapy for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis. Shanghai Archives of Psychiatry, 26, 319-331.